Bankrupt K-V Fights Hologic Bid To Reacquire Makena Rights
Ailing drugmaker K-V Pharmaceutical Co. on Thursday told a New York federal judge that creditor Hologic Inc. is trying to skirt bankruptcy law by seeking worldwide rights to Makena, a drug...To view the full article, register now.
Already a subscriber? Click here to view full article